Promotion of dispersion and anticancer efficacy of hydroxyapatite nanoparticles by the adsorption of fetal bovine serum
Source abstract
Abstract
The biocompatibility and anticancer effect of hydroxyapatite nanoparticles (HAPNs) are compelling and promising in cancer nanomedicine. However, the essential role of fetal bovine serum (FBS) in a biological environment possibly determining the state of agglomeration and intracellular fate of HAPNs (length: ~ 60 nm; width: ~ 20 nm) has never been studied. Here, we investigated the importance of FBS in agglomeration and cell response of HAPNs in human osteosarcoma MG-63 cells. Protein adsorption on the surface of HAPNs after mixing with different concentrations of FBS was confirmed using transmission electron microscope (TEM), attenuated total reflection-Fourier transform infrared (ATR-FTIR) spectroscopy, quartz crystal microbalance with dissipation (QCM-D), and thermogravimetric analysis (TG). The adsorption of serum protein improved dispersed state and stabilization of HAPNs, which was evidenced by dynamic light scattering (DLS), inverted microscope, and scanning electron microscope (SEM). More specifically, the agglomerate size of HAPNs in cell culture medium without FBS was above 1400 nm, while the agglomerate size of HAPNs with 10% FBS was decreased to about 200 nm and maintained for at least five days. Meanwhile, serum protein adsorption on HAPN surface enhanced cellular uptake and anticancer efficacy of HAPNs in MG-63 cells.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Bone health and osteoporosis research · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (44)
Show source-provided references
1. Albanese A, Chan WCW (2011) Effect of gold nanoparticle aggregation on cell uptake and toxicity. ACS Nano 5(7):5478–548910.1021/nn2007496 ↗
2. Anders CB, Chess JJ, Wingett DG, Punnoose A (2015) Serum proteins enhance dispersion stability and influence the cytotoxicity and dosimetry of ZnO nanoparticles in suspension and adherent cancer cell models. Nanoscale Res Lett 10(1):44810.1186/s11671-015-1158-y ↗
3. Barbalinardo M, Caicci F, Cavallini M, Gentili D (2018) Protein corona mediated uptake and cytotoxicity of silver nanoparticles in mouse embryonic fibroblast. Small 14(34):e180121910.1002/smll.201801219 ↗
4. Bauer IW, Li SP, Han YC, Yuan L, Yin MZ (2008) Internalization of hydroxyapatite nanoparticles in liver cancer cells. J Mater Sci-Mater M 19(3):1091–109510.1007/s10856-007-3124-4 ↗
5. Behzadi S, Serpooshan V, Tao W, Hamaly MA, Alkawareek MY, Dreaden EC, Brown D, Alkilany AM, Farokhzad OC, Mahmoudi M (2017) Cellular uptake of nanoparticles: Journey inside the cell. Chem Soc Rev 46(14):4218–424410.1039/C6CS00636A ↗
6. Bruinink A, Wang J, Wick P (2015) Effect of particle agglomeration in nanotoxicology. Arch Toxicol 89(5):659–67510.1007/s00204-015-1460-6 ↗
7. Catalano F, Accomasso L, Alberto G, Gallina C, Raimondo S, Geuna S, Giachino C, Martra G (2015) Uptake: factors ruling the uptake of silica nanoparticles by mesenchymal stem cells: agglomeration versus dispersions, absence versus presence of serum proteins. Small 11(24):2918–291810.1002/smll.201570140 ↗
8. Cedervall T, Lynch I, Lindman S, Berggård T, Thulin E, Nilsson H, Dawson KA, Linse S (2007) Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. P Natl Acad Sci USA 104(7):2050–205510.1073/pnas.0608582104 ↗
9. Charbgoo F, Nejabat M, Abnous K, Soltani F, Taghdisi SM, Alibolandi M, Shier WT, Steele TWJ, Ramezani M (2018) Gold nanoparticle should understand protein corona for being a clinical nanomaterial. J Control Release 272:39–5310.1016/j.jconrel.2018.01.002 ↗
10. Durán N, Silveira CP, Durán M, Martinez DSfT (2015) Silver nanoparticle protein corona and toxicity: a mini-review. J Nanobiotechnol 13:5510.1186/s12951-015-0114-4 ↗
11. Foroozandeh P, Aziz AA (2015) Merging worlds of nanomaterials and biological environment: factors governing protein corona formation on nanoparticles and its biological consequences. Nanoscale Res Lett 10:22110.1186/s11671-015-0922-3 ↗
12. Hadjidemetriou M, Kostarelos K (2017) Nanomedicine: evolution of the nanoparticle corona. Nat Nanotechnol 12(4):288–29010.1038/nnano.2017.61 ↗
13. Halamoda-Kenzaoui B, Ceridono M, Urban P, Bogni A, Ponti J, Gioria S, Kinsner-Ovaskainen A (2017) The agglomeration state of nanoparticles can influence the mechanism of their cellular internalisation. J Nanobiotechnol 15:4810.1186/s12951-017-0281-6 ↗
14. Huang B, Yuan Y, Ding S, Li J, Ren J, Feng B, Li T, Gu Y, Liu C (2015) Nanostructured hydroxyapatite surfaces-mediated adsorption alters recognition of BMP receptor IA and bioactivity of bone morphogenetic protein-2. Acta Biomater 27:275–28510.1016/j.actbio.2015.09.007 ↗
15. Ji Z, Jin X, George S, Xia T, Meng H, Wang X, Suarez E, Zhang H, Hoek EM, Godwin H (2010) Dispersion and stability optimization of TiO2 nanoparticles in cell culture media. Environ Sci Technol 44(19):7309–731410.1021/es100417s ↗
16. Lynch I, Salvati A, Dawson KA (2009) Protein-nanoparticle interactions: what does the cell see? Nat Nanotechnol 4(9):546–54710.1038/nnano.2009.248 ↗
17. Mahmoudi M, Lynch I, Ejtehadi MR, Monopoli MP, Bombelli FB, Laurent S (2011) Protein-nanoparticle interactions: opportunities and challenges. Chem Rev 111(9):5610–563710.1021/cr100440g ↗
18. Maiorano G, Sabella S, Sorce B, Brunetti V, Malvindi MA, Cingolani R, Pompa PP (2010) Effects of cell culture media on the dynamic formation of protein-nanoparticle complexes and influence on the cellular response. ACS Nano 4(12):7481–749110.1021/nn101557e ↗
19. Misra R, Acharya S, Sahoo SK (2010) Cancer nanotechnology: application of nanotechnology in cancer therapy. Drug Discov Today 15(19–20):842–85010.1016/j.drudis.2010.08.006 ↗
20. Monopoli MP, Walczyk D, Campbell A, Elia G, Lynch I, Bombelli FB, Dawson KA (2011) Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J Am Chem Soc 133(8):2525–253410.1021/ja107583h ↗
21. Monopoli MP, Åberg C, Salvati A, Dawson KA (2012) Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol 7:779–78610.1038/nnano.2012.207 ↗
22. Mortensen NP, Hurst GB, Wang W, Foster CM, Nallathamby PD, Retterer ST (2013) Dynamic development of the protein corona on silica nanoparticles: composition and role in toxicity. Nanoscale 5(14):6372–638010.1039/c3nr33280b ↗
23. Mueller KH, Motskin M, Philpott AJ, Routh AF, Shanahan CM, Duer MJ, Skepper JN (2014) The effect of particle agglomeration on the formation of a surface-connected compartment induced by hydroxyapatite nanoparticles in human monocyte-derived macrophages. Biomaterials 35(3):1074–108810.1016/j.biomaterials.2013.10.041 ↗
24. Nguyen VH, Lee B-J (2017) Protein corona: a new approach for nanomedicine design. Int J Nanomed 12:3137–315110.2147/IJN.S129300 ↗
25. Park J, Park J-H, Ock K-S, Ganbold E-O, Song NW, Cho K, Lee SY, Joo S-W (2011) Preferential adsorption of fetal bovine serum on bare and aromatic thiol-functionalized gold surfaces in cell culture media. J Colloid Interf Sci 363(1):105–11310.1016/j.jcis.2011.07.006 ↗
26. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R (2007) Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2(12):751–76010.1038/nnano.2007.387 ↗
27. Piella J, Bastus NG, Puntes V (2017) Size-dependent protein-nanoparticle interactions in citrate-stabilized gold nanoparticles: the emergence of the protein corona. Bioconjugate Chem 28(1):88–9710.1021/acs.bioconjchem.6b00575 ↗
28. Pyrgiotakis G, Blattmann CO, Pratsinis S, Demokritou P (2013) Nanoparticle-nanoparticle interactions in biological media by atomic force microscopy. Langmuir 29(36):11385–1139510.1021/la4019585 ↗
29. Roach P, Farrar D, Perry CC (2005) Interpretation of protein adsorption: Surface-induced conformational changes. J Am Chem Soc 127(22):8168–817310.1021/ja042898o ↗
30. Safi M, Courtois J, Seigneuret M, Conjeaud H, Berret JF (2011) The effects of aggregation and protein corona on the cellular internalization of iron oxide nanoparticles. Biomaterials 32(35):9353–936310.1016/j.biomaterials.2011.08.048 ↗
31. Sasidharan A, Riviere JE, Monteiro-Riviere NA (2015) Gold and silver nanoparticle interactions with human proteins: impact and implications in biocorona formation. J Mater Chem B 3(10):2075–208210.1039/C4TB01926A ↗
32. Schulze C, Schulze C, Kroll A, Schulze C, Kroll A, Lehr C-M, Schäfer UF, Becker K, Schnekenburger J, Schulze Isfort C (2008) Not ready to use-overcoming pitfalls when dispersing nanoparticles in physiological media. Nanotoxicology 2(2):51–6110.1080/17435390802018378 ↗
33. Shannahan J (2017) The biocorona: a challenge for the biomedical application of nanoparticles. Nanotechnol Rev 6(4):345–35310.1515/ntrev-2016-0098 ↗
34. Shi J, Kantoff PW, Wooster R, Farokhzad OC (2017) Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer 17(1):20–3710.1038/nrc.2016.108 ↗
35. Sun Y, Chen Y, Ma X, Yuan Y, Liu C, Kohn J, Qian J (2016) Mitochondria-targeted hydroxyapatite nanoparticles for selective growth inhibition of lung cancer in vitro and in vivo. ACS Appl Mater Inter 8(39):25680–2569010.1021/acsami.6b06094 ↗
36. Swain SK, Sarkar D (2013) Study of BSA protein adsorption/release on hydroxyapatite nanoparticles. Appl Surf Sci 286:99–10310.1016/j.apsusc.2013.09.027 ↗
37. Tang W, Yuan Y, Liu C, Wu Y, Lu X, Qian J (2014) Differential cytotoxicity and particle action of hydroxyapatite nanoparticles in human cancer cells. Nanomedicine 9(3):397–41210.2217/nnm.12.217 ↗
38. Tedja R, Lim M, Amal R, Marquis C (2012) Effects of serum adsorption on cellular uptake profile and consequent impact of titanium dioxide nanoparticles on human lung cell lines. ACS Nano 6(5):4083–409310.1021/nn3004845 ↗
39. Thomas LM, Laura R-L, Vera H, Sandor B, Dominic U, Corinne J, Barbara R-R, Marco L, Alke P-F (2015) Nanoparticle colloidal stability in cell culture media and impact on cellular interactions. Chem Soc Rev 44:6287–630510.1039/C5CS00070J ↗
40. Venditto VJ, Szoka FC Jr (2013) Cancer nanomedicines: so many papers and so few drugs! Adv Drug Deliver Rev 65(1):80–8810.1016/j.addr.2012.09.038 ↗
41. Wassell DTH, Hall RC, Embery G (1995) Adsorption of bovine serum albumin onto hydroxyapatite. Biomaterials 16:697–70210.1016/0142-9612(95)99697-K ↗
42. Wiogo HTR, Lim M, Bulmus V, Yun J, Amal R (2011) Stabilization of magnetic iron oxide nanoparticles in biological media by fetal bovine serum (FBS). Langmuir 27(2):843–85010.1021/la104278m ↗
43. Yang Z, Zhang C (2009) Adsorption/desorption behavior of protein on nanosized hydroxyapatite coatings: a quartz crystal microbalance study. Appl Surf Sci 255(8):4569–457410.1016/j.apsusc.2008.11.078 ↗
44. Zhou H, Lee J (2011) Nanoscale hydroxyapatite particles for bone tissue engineering. Acta Biomater 7(7):2769–278110.1016/j.actbio.2011.03.019 ↗